Tag:
DNage
Latest Headlines
Latest Headlines
Pharming to divest DNage, focus on Rhucin
Dutch biotech company Pharming Group is planning to divest its wholly owned subsidiary DNage and focus on the commercialization of its lead product, Rhucin, a replacement therapy for patients who
